Discovery of 4-[4-({(3R)-1-butyl-3-[(R)-cyclohexyl (hydroxy) methyl]-2, 5-dioxo-1, 4, 9-triazaspiro [5.5] undec-9-yl} methyl) phenoxy] benzoic acid hydrochloride: a …
…, T Nishiyama, K Hisaichi, C Minamoto, M Murota…
Index: Nishizawa, Rena; Nishiyama, Toshihiko; Hisaichi, Katsuya; Minamoto, Chiaki; Murota, Masayuki; Takaoka, Yoshikazu; Nakai, Hisao; Tada, Hideaki; Sagawa, Kenji; Shibayama, Shiro; Fukushima, Daikichi; Maeda, Kenji; Mitsuya, Hiroaki Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 13 p. 4028 - 4042
Full Text: HTML
Citation Number: 7
Abstract
Abstract Based on the original spirodiketopiperazine design framework, further optimization of an orally available CCR5 antagonist was undertaken. Structural hybridization of the hydroxylated analog 4 derived from one of the oxidative metabolites and the new orally available non-hydroxylated benzoic acid analog 5 resulted in another potent orally available CCR5 antagonist 6a as a clinical candidate. Full details of a structure–activity relationship ...
Related Articles:
[Malkov, Andrei V.; Derrien, Nolwenn; Barlog, Maciej; Kocovsky, Pavel Chemistry - A European Journal, 2014 , vol. 20, # 16 p. 4542 - 4547]
Spirodiketopiperazine-based CCR5 antagonist: Discovery of an antiretroviral drug candidate
[Nishizawa, Rena; Nishiyama, Toshihiko; Hisaichi, Katsuya; Minamoto, Chiaki; Matsunaga, Naoki; Takaoka, Yoshikazu; Nakai, Hisao; Jenkinson, Stephen; Kazmierski, Wieslaw M.; Tada, Hideaki; Sagawa, Kenji; Shibayama, Shiro; Fukushima, Daikichi; Maeda, Kenji; Mitsuya, Hiroaki Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 4 p. 1141 - 1145]
[Keck, Gary E.; Boden, Eugene P.; Mabury, Scott A. Journal of Organic Chemistry, 1985 , vol. 50, # 5 p. 709 - 710]
[Russell, Glen A.; Ngoviwatchai, Preecha; Tashtoush, Hasan I. Organometallics, 1988 , vol. 7, p. 696 - 702]
[Russell, Glen A.; Ngoviwatchai, Preecha; Tashtoush, Hasan I. Organometallics, 1988 , vol. 7, p. 696 - 702]